3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
3
INDUSTRY
2
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Interventions
peginterferon alfa-2a
1
nilotinib
1
Imatinib Mesylate
1
4-fluorobenzoyl-TN-14003
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
×
peginterferon alfa-2a
×
Clear all
NCT02381379
2020-09-14
MSIT
Ministry of Health, Malaysia
Phase 3
Unknown
118 enrolled